(MedPage Today) -- Among hospitalized COVID-19 patients with type 2 diabetes, sitagliptin (Januvia) treatment was linked with lower in-hospital mortality, researchers reported.
In a retrospective study of 338 patients admitted in Northern Italy...
Related topics: Type 2 Diabetes, Medical Research
TUESDAY, Sept. 29, 2020 -- Regular use of proton pump inhibitors (PPIs) is associated with an increased risk for type 2 diabetes, according to a study published online Sept. 28 in Gut.
Jinqiu Yuan, Ph.D., from Sun Yat-Sen University in Shenzhen,...
Related topics: Type 2 Diabetes, Medical Research
Research suggests a regular coffee habit can reduce a person's risk of cardiovascular disease, Alzheimer's, cancer, and diabetes.
Reuters
Drinking too much coffee can cause insomnia, restlessness, or a fast heartbeat, especially if...
Related topics: Medical Research, Cardiovascular Disease, Cardiology, Alzheimer's Disease, Cancer, Oncology, Reuters, Insomnia
SGLT2 inhibitors and GLP-1 receptor agonists should be considered in people with type 2 diabetes and chronic kidney disease to protect against heart disease and kidney disease progression, the AHA says. Medscape Medical News
Related topics: Type 2 Diabetes, Type 1 Diabetes, Kidney Disease, Cardiovascular Disease
MONDAY, Sept. 28, 2020 -- The foundation for early heart disease might begin not during childhood or in the years that follow, but in the womb.
Researchers studying nearly 30 years of data from families in Manitoba, Canada, found a strong...
Related topics: Cardiovascular Disease, Medical Research
New research suggests that taking hot baths, soaking in hot tubs or using saunas can prevent cardiovascular diseases such as heart disease, high blood pressure and Type 2 diabetes. The research was presented last week at the Annual Meeting of the...
Related topics: Cardiovascular Disease, Cardiology, Medical Research, Hypertension, Blood Pressure, Type 2 Diabetes
FRIDAY, Sept. 25, 2020 -- For patients with type 2 diabetes, once-weekly insulin icodec has glucose-lowering efficacy comparable to once-daily insulin glargine, according to a study published online Sept. 22 in the New England Journal of Medicine...
Related topics: Insulin, Type 2 Diabetes, Medical Research
(MedPage Today) -- The virtual European Association for the Study of Diabetes 2020 meeting featured new insights and developments in helping people with type 1 and type 2 diabetes improve glycemic control and related outcomes. Some of the new...
Related topics: Medical Research, Type 2 Diabetes, Type 1 Diabetes
(MedPage Today) -- People with type 2 diabetes who faced housing insecurity had worse glycemic outcomes, a new study found.
Among adults with type 2 diabetes in Northern California, those who had at least one address change in a year showed...
Related topics: Type 2 Diabetes, Medical Research
In a large study of commercial and private pilots with diabetes who followed strict rules, 98% of glucose levels were in target range and no pilot was incapacitated. Medscape Medical News
Related topics: Insulin, Medical Research
Another study has linked the popular drug used to treat type-2 diabetes, metformin, with a decreased risk of developing Alzheimer’s disease later in life, but that may not mean what you think it does. Dementia, including Alzheimer’s, is...
Related topics: Medical Research, Dementia, Type 2 Diabetes, Alzheimer's Disease
THURSDAY, Sept. 24, 2020 -- For individuals with type 2 diabetes, sodium glucose cotransporter 2 (SGLT2) inhibitors are associated with a reduced risk for cardiovascular events during short-term follow-up, according to a study published online...
Related topics: Type 2 Diabetes, Cardiology, Medical Research
(MedPage Today) -- Weight loss alone did not explain the cardiovascular and survival benefits of bariatric surgery in people with obesity and type 2 diabetes, according to an observational study.
Risk of major adverse cardiovascular events (MACE...
Related topics: Cardiology, Obesity, Type 2 Diabetes, Medical Research
Adapting to a Westernized environment appears to have adverse cardiometabolic effects in the long run, and in particular, among children of immigrants from non-Western nations, a Swedish study shows. Medscape Medical News
Related topics: Medical Research
One hundred years after the discovery of insulin, we are approaching a new frontier in diabetes management, says Dr Harpreet Bajaj. Medscape Diabetes & Endocrinology
Related topics: Insulin, Medical Research, Endocrinology
Regular hot tub bathing, or 'heat therapy' may benefit patients with type 2 diabetes shows a study from Japan, where it's common for people to have a hot tub at home and use it several times a week. Medscape Medical News
Related topics: Blood Pressure, Type 2 Diabetes, Medical Research
THURSDAY, Sept. 24, 2020 -- Children who need to take oral steroids for chronic or life-threatening conditions can experience serious side effects, according to new research.
Children with autoimmune disorders such as juvenile arthritis, psoriasis...
Related topics: Medical Research, Arthritis, Psoriasis
(MedPage Today) -- The FDA's proposed move beyond a narrow focus on ischemic cardiovascular risk in type 2 diabetes trial requirements was largely met with acceptance as inevitable, although some cardiologists worried about potential for a drop...
Related topics: Type 2 Diabetes, Food And Drug Administration, Cardiology
Obstructive sleep apnea (OSA) affects more than one billion people worldwide. Evidence suggests OSA can alter the gut microbiome (GM) and may promote OSA-associated co-morbidities, including diabetes, hypertension and cognitive problems. Researchers...
Related topics: Microbiome, Sleep Apnea, Obstructive Sleep Apnea, Hypertension, Medical Research
WEDNESDAY, Sept. 23, 2020 -- For older adults with type 2 diabetes, cognitive decline is slower and dementia risk reduced for those receiving metformin, according to a study published online Sept. 23 in Diabetes Care.
Katherine Samaras, M.B.B.S.,...
Related topics: Type 2 Diabetes, Dementia, Medical Research